
Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking at a drug called G1T38 with fulvestrant for breast cancer that has spread (advanced breast cancer).
It is open to people with advanced breast cancer that has continued to get worse while having hormone therapy.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rebecca Roylance
G1 Therapeutics
University College London Hospitals NHS Foundation Trust
Freephone 0808 800 4040
Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.